na-asp-2
Vaccineexperimental
Clinical trial activity
4 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2005 (NCT00120081)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Erysiphe necatorImmunity, active
Erysiphe necator immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- na-asp-2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00939198 | N/A | Aug 1, 2009 | Albert B. Sabin Vaccine Institute |
| NCT00603889 | N/A | Mar 1, 2008 | Albert B. Sabin Vaccine Institute, George Washington University |
| NCT00473967 | Phase 1 | May 1, 2007 | Albert B. Sabin Vaccine Institute, George Washington University, Oswaldo Cruz Foundation, University of London |
| NCT00120081 | Phase 1 | Apr 1, 2005 | Baylor University, Bill and Melinda Gates Foundation, George Washington University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Albert B. Sabin Vaccine Institute | Academic/Hospital | 3 | 3 | 2 | 2007 |
| George Washington University | Academic/Hospital | 3 | 0 | 2 | 2005 |
| Baylor University | Academic/Hospital | 1 | 1 | 1 | 2005 |
| Bill and Melinda Gates Foundation | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Oswaldo Cruz Foundation | Academic/Hospital | 1 | 0 | 1 | 2007 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2007 |
6 organizations
Page 1 / 1